Zoetis (ZTS) EBITDA Margin (2012 - 2026)

Zoetis (ZTS) has 15 years of EBITDA Margin data on file, last reported at 36.83% in Q1 2026.

• On a quarterly basis, EBITDA Margin fell 157.0% year-over-year to 36.83% in Q1 2026; TTM through Mar 2026 was 38.17%, a 50.0% increase from a year earlier, with the FY2025 full-year figure at 38.83%, up 123.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 36.83%, up from 35.23% in the prior quarter.
• Over the last five years, EBITDA Margin for ZTS reached as high as 41.69% in Q1 2022 and fell as low as 33.35% in Q4 2023.
• Historically, EBITDA Margin has averaged 37.75% across 5 years, with a median of 38.08% in 2024.
• Across the five-year window, EBITDA Margin soared 1449 bps in 2022 and plunged 449 bps in 2023, its largest moves.
• Year by year, EBITDA Margin stood at 35.69% in 2022, then decreased by 7 bps to 33.35% in 2023, then grew by 3 bps to 34.4% in 2024, then grew by 2 bps to 35.23% in 2025, then climbed by 5 bps to 36.83% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 36.83% in Q1 2026, 35.23% in Q4 2025, and 40.17% in Q3 2025.